Form 8-K - Current report:
SEC Accession No. 0001437749-20-002240
Filing Date
2020-02-11
Accepted
2020-02-11 07:05:23
Documents
3
Period of Report
2020-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20200206_8k.htm 8-K 26256
2 EXHIBIT 99.1 ex_171640.htm EX-99.1 9621
3 EXHIBIT 99.2 ex_171641.htm EX-99.2 335207
  Complete submission text file 0001437749-20-002240.txt   372349
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 20593883
SIC: 2834 Pharmaceutical Preparations